首页> 外文会议>World congress on medical physics and biomedical engineering;International congress of the IUPESM >EVALUATION OF GLOMERULAR FILTRATION RATE IN END-STAGE RENAL DISEAS PATIENTS: OLD AND NEW PREDICTION FORMULAS
【24h】

EVALUATION OF GLOMERULAR FILTRATION RATE IN END-STAGE RENAL DISEAS PATIENTS: OLD AND NEW PREDICTION FORMULAS

机译:终末期肾脏疾病患者肾小球滤过率的评估:新旧预测公式

获取原文

摘要

An accurate evaluation of glomerular filtration rate (GFR) is mandatory in patients at the end-stage of chronic kidney disease (CKD stages 4 & 5), to assess the residual renal function, which is an important indicator for initiation of maintenance dialysis. Furthermore, the dosage of many drugs, cleared mainly by the kidneys, must be tapered according to residual renal function, to avoid excessive administration of drugs, which may induce systemic and/or renal toxicity.The gold standards for the measurement of GFR are inulin clearance or radioisotopic methods, which are not feasible to routine use. Therefore, in clinical practice, renal function is commonly evaluated by measuring serum creatinine (SCr) or 24-hour creatinine clearance (CCr). Since creatinine is produced by muscle cells, its daily production is strictly related to the amount of body muscle mass. Thus, SCr is influenced not only by the impairment of GFR, but also by the amount of body muscle mass of individual patients. The measurement of 24h-CCr is not influenced by body composition of the patients. Unfortunately, CCr is neither precise, since it overestimates GFR, neither accurate, due to the high variability of its measurement. Indeed, the major pitfall of CCr is the high variability in the measurement of 24h urinary creatinine excretion (1,2). To overcome this problem different formulas have been proposed to predict GFR from SCr and some anthropometric data (3-6). The accuracy of these formulas is still debated. Recently, we proposed a new method which predicts CCr and GFR from the value of SCr combined with the value of body cell mass (BCM) measured by means of electrical bioimpedance (BIA) (bcmGFR) (7-9). BIA is a simple and validated method to evaluate body composition even in end-stage renal patients (10-12). BCM is the body compartment which is related to muscle mass, where creatinine is produced. Our previous data demonstrate that, in renal patients with different degree of renal function and body mass index, GFR can be predicted from SCr and BCM, more accurately than from 24h CCr and CG CCr (9)Aim of this study was to compare the adequacy of different method used in clinical practice to evaluate GFR in end-stage renal disease (ESRD) patients.
机译:在慢性肾脏病末期(CKD 4和5期)患者中,必须对肾小球滤过率(GFR)进行准确评估,以评估残余肾功能,这是开始进行维持性透析的重要指标。此外,必须根据残余的肾功能逐渐减少主要由肾脏清除的许多药物的剂量,以避免过多地给药药物,这可能会引起全身和/或肾脏毒性。 测量GFR的金标准是菊粉清除率或放射性同位素方法,这对于常规使用是不可行的。因此,在临床实践中,通常通过测量血清肌酐(SCr)或24小时肌酐清除率(CCr)来评估肾功能。由于肌酸酐是由肌细胞产生的,因此肌酐的日产量与人体肌肉量紧密相关。因此,SCr不仅受GFR损伤的影响,而且还受各个患者身体肌肉量的影响。 24h-CCr的测量不受患者身体成分的影响。不幸的是,CCr不够精确,因为由于其测量的高度可变性,它高估了GFR,也不准确。确实,CCr的主要缺陷在于24h尿肌酐排泄量的高变异性(1,2)。为了克服这个问题,已经提出了不同的公式来根据SCr和一些人体测量数据来预测GFR(3-6)。这些公式的准确性尚有争议。最近,我们提出了一种新方法,该方法可通过SCr值与通过电生物阻抗(BIA)(bcmGFR)测量的体细胞质量(BCM)值相结合来预测CCr和GFR(7-9)。 BIA是一种简单有效的方法,即使在终末期肾病患者中也可评估其身体成分(10-12)。 BCM是与肌肉质量相关的体腔,在肌腔中会产生肌酸酐。我们以前的数据表明,在肾功能和体重指数不同的肾病患者中,从SCr和BCM预测GFR的准确性要比从24h CCr和CG CCr预测的更为准确(9) 这项研究的目的是比较临床实践中使用不同方法评估终末期肾病(ESRD)患者的GFR的适当性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号